Total submissions: 24
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000041601 | SCV000050840 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000041601 | SCV000065297 | benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Ser524Tyr in Exon 12 of SCN5A: This variant is not expected to have clinical s ignificance because it has been identified in 3.4% (114/3402) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs41313691). |
Eurofins Ntd Llc |
RCV000041601 | SCV000225723 | benign | not specified | 2014-11-22 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000202694 | SCV000257777 | likely benign | Brugada syndrome 1; Long QT syndrome 3 | 2015-02-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000058430 | SCV000291780 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000238899 | SCV000297007 | benign | Long QT syndrome 3; Brugada syndrome | 2015-11-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000041601 | SCV000306535 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000242695 | SCV000320011 | benign | Cardiovascular phenotype | 2015-11-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000316117 | SCV000444146 | benign | Long QT syndrome 3 | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Athena Diagnostics Inc | RCV000058430 | SCV000843705 | benign | not provided | 2018-03-08 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001841590 | SCV000903048 | benign | Cardiac arrhythmia | 2018-03-15 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000058430 | SCV000987366 | benign | not provided | criteria provided, single submitter | clinical testing | ||
Mendelics | RCV000987230 | SCV001136479 | benign | Brugada syndrome 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001144118 | SCV001304697 | likely benign | Dilated cardiomyopathy 1E | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV001144119 | SCV001304698 | benign | Sick sinus syndrome 1 | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV001144120 | SCV001304699 | benign | Ventricular fibrillation, paroxysmal familial, type 1 | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000987230 | SCV001306715 | benign | Brugada syndrome 1 | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV001146003 | SCV001306716 | likely benign | Progressive familial heart block, type 1A | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
ARUP Laboratories, |
RCV000058430 | SCV001474118 | benign | not provided | 2023-03-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000058430 | SCV001944441 | benign | not provided | 2020-04-22 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31043699, 15992732, 16453024, 26332594, 32880476) |
Ce |
RCV000058430 | SCV002585972 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | SCN5A: BP4, BS1, BS2 |
Fulgent Genetics, |
RCV002496657 | SCV002813754 | benign | Brugada syndrome 1; Long QT syndrome 3; Sick sinus syndrome 1; Progressive familial heart block, type 1A; Ventricular fibrillation, paroxysmal familial, type 1; Dilated cardiomyopathy 1E; SUDDEN INFANT DEATH SYNDROME; Atrial fibrillation, familial, 10 | 2022-04-20 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003486622 | SCV004239650 | benign | Cardiomyopathy | 2023-01-09 | criteria provided, single submitter | clinical testing | |
Cardiovascular Biomedical Research Unit, |
RCV000058430 | SCV000089950 | not provided | not provided | no assertion provided | literature only | This variant has been reported in the following publications (PMID:19841300;PMID:20129283;PMID:16453024;PMID:15992732). |